G. Simonneau, D. Montani, D. S. Celermajer, C. P. Denton, M. A. Gatzoulis et al., Haemodynamic definitions and updated clinical classification of pulmonary hypertension, Eur. Respir. J, vol.53, p.1801913, 2019.

M. Humbert, Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Pathophysiology, Eur. Respir. Rev, vol.19, pp.59-63, 2010.

M. Humbert, C. Guignabert, S. Bonnet, P. Dorfmuller, J. R. Klinger et al., Pathology and pathobiology of pulmonary hypertension: State of the art and research perspectives, Eur. Respir. J, vol.53, p.1801887, 2019.

B. Claustrat, J. Leston, and . Melatonin, Physiological effects in humans, Neurochirurgie, vol.61, pp.77-84, 2015.

L. Xu, Y. Su, Y. Zhao, X. Sheng, R. Tong et al., Melatonin differentially regulates pathological and physiological cardiac hypertrophy: Crucial role of circadian nuclear receptor RORalpha signaling, J. Pineal Res, p.12579, 2019.

T. Misaka, A. Yoshihisa, T. Yokokawa, T. Sato, M. Oikawa et al., Plasma levels of melatonin in dilated cardiomyopathy, J Pineal Res, vol.66, p.12564, 2019.

H. Sun, A. M. Gusdon, and S. Qu, Effects of melatonin on cardiovascular diseases: Progress in the past year, Curr. Opin. Lipidol, vol.27, pp.408-413, 2016.

S. Habtemariam, M. Daglia, A. Sureda, Z. Selamoglu, M. F. Gulhan et al., Melatonin and Respiratory Diseases: A Review, Curr. Top. Med. Chem, vol.17, pp.467-488, 2017.

F. Moradkhani, M. Moloudizargari, M. Fallah, N. Asghari, H. Heidari-khoei et al., Immunoregulatory role of melatonin in cancer, J. Cell. Physiol, vol.235, pp.745-757, 2020.

R. Das, L. Balonan, H. J. Ballard, and S. Ho, Chronic hypoxia inhibits the antihypertensive effect of melatonin on pulmonary artery, Int. J. Cardiol, vol.126, pp.340-345, 2008.

H. Jin, Y. Wang, L. Zhou, L. Liu, P. Zhang et al., Melatonin attenuates hypoxic pulmonary hypertension by inhibiting the inflammation and the proliferation of pulmonary arterial smooth muscle cells, J. Pineal Res, vol.57, pp.442-450, 2014.

J. Zhang, X. Lu, M. Liu, H. Fan, H. Zheng et al., Melatonin inhibits inflammasome-associated activation of endothelium and macrophages attenuating pulmonary arterial hypertension, Cardiovasc. Res, 2019.

M. W. Hung, H. M. Yeung, C. F. Lau, A. M. Poon, G. L. Tipoe et al., Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats, Int. J. Mol. Sci, vol.18, p.1125, 2017.

F. Torres, A. Gonzalez-candia, C. Montt, G. Ebensperger, M. Chubretovic et al., Melatonin reduces oxidative stress and improves vascular function in pulmonary hypertensive newborn sheep, J. Pineal Res, vol.58, pp.362-373, 2015.

A. Gonzalez-candia, A. A. Candia, E. G. Figueroa, E. Feixes, C. Gonzalez-candia et al., Melatonin long-lasting beneficial effects on pulmonary vascular reactivity and redox balance in chronic hypoxic ovine neonates, J. Pineal Res, p.12613, 2020.

C. R. Astorga, A. Gonzalez-candia, A. A. Candia, E. G. Figueroa, D. Canas et al., Melatonin Decreases Pulmonary Vascular Remodeling and Oxygen Sensitivity in Pulmonary Hypertensive Newborn Lambs, Front. Physiol, vol.9, p.185, 2018.

G. Maarman, D. Blackhurst, F. Thienemann, L. Blauwet, G. Butrous et al., Melatonin as a preventive and curative therapy against pulmonary hypertension, J. Pineal Res, vol.59, pp.343-353, 2015.

R. Wang, S. Zhou, P. Wu, M. Li, X. Ding et al., Identifying Involvement of H19-miR-675-3p-IGF1R and H19-miR-200a-PDCD4 in Treating Pulmonary Hypertension with Melatonin, Mol. Ther. Nucleic Acids, vol.13, pp.44-54, 2018.

N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J. L. Vachiery et al., Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), Eur. Heart J, vol.30, pp.2493-2537, 2009.

M. M. Hoeper, H. J. Bogaard, R. Condliffe, R. Frantz, D. Khanna et al., Definitions and diagnosis of pulmonary hypertension, J. Am. Coll. Cardiol, issue.25, pp.42-50, 2013.

L. W. Geenen, V. J. Baggen, T. Koudstaal, K. A. Boomars, J. A. Eindhoven et al., The prognostic value of various biomarkers in adults with pulmonary hypertension; a multi-biomarker approach, Am. Heart J, vol.208, pp.91-99, 2019.

M. E. Menting, J. S. Mcghie, L. P. Koopman, W. B. Vletter, W. A. Helbing et al., Normal myocardial strain values using 2D speckle tracking echocardiography in healthy adults aged 20 to 72 years, Echocardiography, vol.33, pp.1665-1675, 2016.

N. Galie, M. Humbert, J. L. Vachiery, S. Gibbs, I. Lang et al., ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the, ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), vol.37, pp.67-119, 2015.

L. Tu, A. Desroches-castan, C. Mallet, L. Guyon, A. Cumont et al., Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension, Circ. Res, vol.124, pp.846-855, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02007505

L. Hedlund, M. M. Lischko, M. D. Rollag, and G. D. Niswender, Melatonin: Daily cycle in plasma and cerebrospinal fluid of calves, Science, vol.195, pp.686-687, 1977.

R. L. Sack, A. J. Lewy, D. L. Erb, W. M. Vollmer, and C. M. Singer, Human melatonin production decreases with age, J. Pineal Res, vol.3, pp.379-388, 1986.

N. Zisapel, New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation, Br. J. Pharmacol, vol.175, pp.3190-3199, 2018.

C. Cajochen, K. Krauchi, and A. Wirz-justice, Role of melatonin in the regulation of human circadian rhythms and sleep, J. Neuroendocrinol, vol.15, pp.432-437, 2003.

T. A. Wehr, Melatonin and seasonal rhythms, J. Biol. Rhythms, vol.12, pp.518-527, 1997.

P. S. Backlund, H. F. Urbanski, M. A. Doll, D. W. Hein, M. Bozinoski et al., Daily Rhythm in Plasma N-acetyltryptamine, J. Biol. Rhythms, vol.32, pp.195-211, 2017.

T. Fukuda, N. Akiyama, M. Ikegami, H. Takahashi, A. Sasaki et al., Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors, J. Neuropathol. Exp. Neurol, vol.69, pp.498-510, 2010.

M. V. Abrahao, N. F. Santos, W. M. Kuwabara, F. G. Amaral, . Do-carmo et al., Identification of insulinregulated aminopeptidase (IRAP) in the rat pineal gland and the modulation of melatonin synthesis by angiotensin IV, Brain Res, vol.1704, pp.40-46, 2019.

J. Qiu, J. Zhang, Y. Zhou, X. Li, H. Li et al., MicroRNA-7 inhibits melatonin synthesis by acting as a linking molecule between leptin and norepinephrine signaling pathways in pig pineal gland, J. Pineal Res, p.12552, 2019.

W. J. Drijfhout, A. G. Van-der-linde, J. B. De-vries, C. J. Grol, and B. H. Westerink, Microdialysis reveals dynamics of coupling between noradrenaline release and melatonin secretion in conscious rats, Neurosci. Lett, vol.202, pp.185-188, 1996.

C. Schomerus and H. W. Korf, Mechanisms regulating melatonin synthesis in the mammalian pineal organ, Ann. N. Y. Acad. Sci, vol.1057, pp.372-383, 2005.

S. Velez-roa, A. Ciarka, B. Najem, J. L. Vachiery, and R. Naeije, Increased sympathetic nerve activity in pulmonary artery hypertension, Circulation, vol.110, pp.1308-1312, 2004.

F. S. De-man, L. Tu, M. L. Handoko, S. Rain, G. Ruiter et al., Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension, Am. J. Respir. Crit. Care Med, vol.186, pp.780-789, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00905193

B. A. Maron and J. A. Leopold, The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension, Pulm. Circ, vol.4, pp.200-210, 2013.

R. K. Sharma, A. C. Oliveira, S. Kim, K. Rigatto, J. Zubcevic et al., Involvement of Neuroinflammation in the Pathogenesis of Monocrotaline-Induced Pulmonary Hypertension, Hypertension, vol.71, pp.1156-1163, 2018.

F. S. De-man, M. L. Handoko, C. Guignabert, and H. J. Bogaard, Vonk-Noordegraaf, A. Neurohormonal axis in patients with pulmonary arterial hypertension: Friend or foe?, Am. J. Respir. Crit. Care Med, vol.187, pp.14-19, 2013.

M. M. Maclean, The serotonin hypothesis in pulmonary hypertension revisited: Targets for novel therapies, Grover Conference Series). Pulm. Circ, 2017.

Z. Jiki, S. Lecour, and F. Nduhirabandi, Cardiovascular Benefits of Dietary Melatonin: A Myth or a Reality?, Front. Physiol, vol.9, p.528, 2018.

D. X. Tan, L. C. Manchester, E. Esteban-zubero, Z. Zhou, and R. J. Reiter, Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism, Molecules, vol.20, pp.18886-18906, 2015.

A. Gonzalez-candia, M. Veliz, C. Carrasco-pozo, R. L. Castillo, J. C. Cardenas et al., Antenatal melatonin modulates an enhanced antioxidant/pro-oxidant ratio in pulmonary hypertensive newborn sheep, Redox Biol, vol.22, p.101128, 2019.

A. Ciarka, V. Doan, S. Velez-roa, R. Naeije, and P. Van-de-borne, Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension, Am. J. Respir. Crit. Care Med, vol.181, pp.1269-1275, 2010.

P. R. Forfia, S. C. Mathai, M. R. Fisher, T. Housten-harris, A. R. Hemnes et al., Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension, Am. J. Respir. Crit. Care Med, vol.177, pp.1364-1369, 2008.